The decline in mRNA is short-lived
In 2020 and early 2021, dips for Moderna typically persisted for weeks and in a couple of times, for months. In stark contrast, after Moderna's entry to the S&P, dips are short lived, typically lasting only for hours or even mere minutes. Sure interested retail investors who want in are crossing their fingers calmly waiting for the best possible bargain (very reasonable if you ask me), but institutional investors simply are not interested in waiting, they just keep on buying. Bad news for the Michael Burry wannabe trolls on this board.$Moderna, Inc.(MRNA)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。